Skip to main content
Clinical Trials/NCT00512590
NCT00512590
Completed
N/A

Effects of Guided Imagery on Pain, Distress, Functional Status and Self-Efficacy in Hispanics Diagnosed With Fibromyalgia

Florida International University1 site in 1 country14 target enrollmentApril 2005

Overview

Phase
N/A
Intervention
Not specified
Conditions
Fibromyalgia
Sponsor
Florida International University
Enrollment
14
Locations
1
Primary Endpoint
Pain as measured by Short-Form McGill Pain Questionnaire
Status
Completed
Last Updated
18 years ago

Overview

Brief Summary

The purpose of this pilot study was to test the effects of a 10-week relaxation and guided imagery intervention on pain perception, functional status, self-efficacy and levels of distress in Hispanic adults diagnosed with fibromyalgia.

Detailed Description

Fibromyalgia (FM), a chronic widespread pain condition with an unknown pathogenesis and no known cure, affects 2 to 4 million persons in the adult US population. One of the most common conditions seen in rheumatology clinics world wide, including the US, Mexico, and Spain, FM is accompanied by various co-occurring symptoms such as fatigue, disturbed sleep, stiffness and depression. While studies of fibromyalgia in Hispanics have been reported in Spain, Brazil and Argentina, very few such studies have been reported in the United States. This gap exists despite data indicating that there are a reported 16 million Hispanics with rheumatic diseases in the US and that Hispanics (self-identified) form the fastest growing minority group in this country.

Registry
clinicaltrials.gov
Start Date
April 2005
End Date
June 2006
Last Updated
18 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • ages 18 and older
  • diagnosis of fibromyalgia based on the American College of Rheumatology criteria and documented by the patient's primary physician
  • a minimum of a 6th grade education level
  • an ability to understand and sign the consent form and understand and complete the intervention (pencil and paper) assignments.

Exclusion Criteria

  • presence of other systemic rheumatologic conditions such as rheumatoid arthritis, lupus, and/or Sjogren's Disease
  • adequate functional status as indicated by a Fibromyalgia Impact Questionnaire score \< 20
  • inadequate cognitive status as evidenced by a Mini-Mental State Exam score \< 25
  • history of epilepsy
  • major communicative disorder.

Outcomes

Primary Outcomes

Pain as measured by Short-Form McGill Pain Questionnaire

Time Frame: 10 weeks

Secondary Outcomes

  • Functional Status as measured by the Fibromyalgia Impact Questionnaire(10 weeks)
  • Self-Efficacy as measured by the Arthritis Self-Efficacy Scale adapted for FM(10 weeks)
  • Distress as measured by the 17-item Mental Health Inventory(10 weeks)

Study Sites (1)

Loading locations...

Similar Trials